Baillie Gifford - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$11,631
+34.3%
618
+13.6%
0.00%
Q4 2022$8,660
-3.8%
5440.0%0.00%
Q3 2022$9,000
+12.5%
5440.0%0.00%
Q2 2022$8,000
-38.5%
5440.0%0.00%
Q1 2022$13,0000.0%5440.0%0.00%
Q4 2021$13,000
+44.4%
5440.0%0.00%
Q3 2021$9,000
-30.8%
5440.0%0.00%
Q2 2021$13,000
-7.1%
5440.0%0.00%
Q1 2021$14,000
-50.0%
544
+2.3%
0.00%
Q4 2020$28,0005320.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders